Author(s): Meinardi MT, Gietema JA, Van-der GWT, Van-Veldhuisen DJ, Runne MA, et al.
PATIENTS AND METHODS: Eighty-seven patients treated with cisplatin-containing chemotherapy before 1987 who were in remission for at least 10 years and whose ages were ≤ 50 years at the time of analysis were evaluated for the occurrence of cardiovascular events. Sixty-two of 87 patients were additionally evaluated for cardiac damage and cardiovascular risk factors. Their cardiovascular risk profile was compared with that of 40 patients with comparable age and follow-up duration treated with orchidectomy only for stage I disease.
Referred From: https://ascopubs.org/doi/10.1200/JCO.2000.18.8.1725
Author(s): Fernandes DD, Louzada ML, Souza CA, Matzinger F
Author(s): Schimmel K, Richel D, Van-Den BRB, Guchelaar HJ
Author(s): Pérez-Callejo D, Torrente M, Brenes MA, Núñez B, Provencio M
Author(s): Biasillo G, Cipolla CM, Cardinale D
Author(s): Fukuda M, Oka M, Itoh N, Sakamoto T, Mori H, et al.
Author(s): Herradón E, González C, Uranga JA, Abalo R, Martín MI, et al.
Author(s): Stefenelli T, Kuzmits R, Ulrich W, Glogar D
Author(s): Sawant J, Prakruthi AD, Daddi J, Ghosh A, Joshi A, et al.
Author(s): Schwarzer S, Eber B, Greinix H, Lind P
Author(s): Yusuf SW, Razeghi P, Yeh ET
Author(s): Curigliano G, Cardinale D, Suter T , Plataniotis G, De Azambuja E, et al.